Angelo Belotti

Angelo Belotti

UNVERIFIED PROFILE

Are you Angelo Belotti?   Register this Author

Register author
Angelo Belotti

Angelo Belotti

Publications by authors named "Angelo Belotti"

Are you Angelo Belotti?   Register this Author

12Publications

287Reads

35Profile Views

Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: Early in vivo cardiovascular effects.

Eur J Pharmacol 2018 Nov 7;838:85-90. Epub 2018 Sep 7.

Cardiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University, Cardiothoracic Department, Spedali Civili of Brescia, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00142999183053
Publisher Site
http://dx.doi.org/10.1016/j.ejphar.2018.09.014DOI Listing
November 2018

Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study.

Leukemia 2018 08 30;32(8):1803-1807. Epub 2018 Jan 30.

Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0024-1DOI Listing
August 2018

Mechanism of cardiovascular toxicity by proteasome inhibitors: New paradigm derived from clinical and pre-clinical evidence.

Eur J Pharmacol 2018 Jun 15;828:80-88. Epub 2018 Mar 15.

Cardiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University, Cardiothoracic Department, Spedali Civili of Brescia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2018.03.022DOI Listing
June 2018

Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.

Clin Lymphoma Myeloma Leuk 2015 Apr 23;15(4):208-13. Epub 2014 Oct 23.

Division of Hematology, Ospedale San Gerardo - Università degli Studi Milano Bicocca, Monza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.10.001DOI Listing
April 2015

Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications.

Leuk Res 2015 Jan 15;39(1):88-91. Epub 2014 Nov 15.

Department of Medicine and Medical Specialities, "Ca' Granda" Foundation IRCCS, University of Milan, Via F. Sforza 35, 20122 Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.11.003DOI Listing
January 2015

Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis.

Mediterr J Hematol Infect Dis 2014 1;6(1):e2014042. Epub 2014 Jun 1.

Hematology Division, San Gerardo Hospital, Monza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2014.042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063602PMC
June 2014

A Case of Atypical Delayed and Prolonged Hematologic Toxicity With Azacitidine in Chronic Myelomonocytic Leukemia (CMML) and Review of Literature.

Mediterr J Hematol Infect Dis 2012 13;4(1):e2012017. Epub 2012 Mar 13.

Divisione di Ematologia, Ospedale San Gerardo - Università degli studi Milano Bicocca, Monza, Italia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2012.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340986PMC
October 2012

Circulating endothelial cells and endothelial activation in essential thrombocythemia: results from CD146+ immunomagnetic enrichment--flow cytometry and soluble E-selectin detection.

Am J Hematol 2012 Mar 21;87(3):319-20. Epub 2011 Dec 21.

Ospedale San Gerardo-Universita' Milano Bicocca, Clinica Ematologica, Monza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.22264DOI Listing
March 2012